Literature DB >> 18498809

Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients.

Albert Castellheim1, Tom N Hoel, Vibeke Videm, Erik Fosse, Anne Pharo, Jan L Svennevig, Arnt E Fiane, Tom E Mollnes.   

Abstract

BACKGROUND: The purpose of this study was to investigate the cytokine and chemokine profile in low-risk patients undergoing off-pump and on-pump coronary artery bypass grafting (CABG) surgery by use of a broad panel of cytokines and chemokines.
METHODS: Eight consecutive blood samples were obtained from patients enrolled into a prospective, randomized study comparing off-pump and on-pump CABG in a low-risk population. Eleven patients from each group were randomly selected for analysis of 25 different cytokines and chemokines using multiplex technology. Data were compared using two-way repeated measures analysis of variance.
RESULTS: Of the 25 biomarkers analyzed, 11 were not detected while 14 increased significantly in both groups. Only three mediators, eotaxin, macrophage inflammatory protein (MIP)-1beta, and interleukin (IL)-12 were significantly different between the two groups, increasing more in the on-pump than in the off-pump group (p < 0.001, p < 0.01, and p < 0.05, respectively). There was a marked, comparable increase in the concentrations of the cytokines IL-6, IL-10, IL-15, and IL-1Ra as well as the chemokines inducible protein (IP)-10, monokine induced by interferon gamma (MIG), monocyte chemoattractant protein 1 (MCP-1), and regulated on activation, normal T cell expressed and secreted (RANTES) in both groups (p < 0.001 for all). There was only a modest, but still statistically significant, increase in IL-8, tumor necrosis factors alpha, and IL-2R, without any intergroup differences. When corrected for hemodilution the production of the antiinflammatory biomarkers IL-1Ra and IL-10 were significantly higher in the on-pump group (p < 0.001 for both).
CONCLUSIONS: The cytokine and chemokine production profile of the inflammatory response associated with CABG is largely similar using the off-pump and on-pump techniques in low-risk patients, but slightly higher concentrations of eotaxin, MIP-1beta, and IL-12 were found in the on-pump group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498809     DOI: 10.1016/j.athoracsur.2008.03.012

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  What Are the Predictors of Atrial Fibrillation in Coronary Artery Bypass Grafting?

Authors:  Orhan Gokalp; Levent Yilik; Hasan Iner; Gamze Gokalp
Journal:  Tex Heart Inst J       Date:  2017-02-01

2.  Eotaxin-2 induces monocytic apoptosis in patients who have undergone coronary artery bypass surgery and in THP-1 cells in vitro regulated by thrombomodulin.

Authors:  Yi-Wen Lin; Chun-Yao Huang; Chun-Min Shih; Yi-Ting Tsai; Chin-Sheng Lin; Chih-Yuan Lin; Chi-Yuan Li; Shih-Hurng Loh; Cheng-Yen Lin; Feng-Yen Lin; Chien-Sung Tsai
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

Review 3.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Enhanced intracellular heat shock protein 70 expression of leukocytes and serum interleukins release: comparison of on-pump and off-pump coronary artery surgery.

Authors:  Chih-Yuan Lin; Tung-Lin Yang; Gou-Jieng Hong; Chi-Yuan Li; Feng-Yen Lin; Chien-Sung Tsai
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

5.  Early blood biomarkers predict organ injury and resource utilization following complex cardiac surgery.

Authors:  Tad Kim; George J Arnaoutakis; Azra Bihorac; Tomas D Martin; Philip J Hess; Charles T Klodell; Curtis G Tribble; A Ahsan Ejaz; Lyle L Moldawer; Thomas Mark Beaver
Journal:  J Surg Res       Date:  2009-10-06       Impact factor: 2.192

6.  Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation.

Authors:  Orfeas Liangos; Sophie Domhan; Christian Schwager; Martin Zeier; Peter E Huber; Francesco Addabbo; Michael S Goligorsky; Lynn Hlatky; Bertrand L Jaber; Amir Abdollahi
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

7.  The association of systemic inflammatory markers with indicators of stress and cardiac necrosis in patients undergoing aortic valve replacement and revascularization surgeries.

Authors:  A Saracevic; I Medved; S Hrabric Vlah; A Kozmar; L Bilic-Zulle; A M Simundic
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

8.  State of the art in cardiovascular perfusion: now and in the next decade.

Authors:  F Merkle; B Haupt; A El-Essawi; R Hetzer
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

9.  Growth factors serum levels in coronary artery disease patients scheduled for bypass surgery: perioperative dynamics and comparisons with healthy volunteers.

Authors:  Inga Karu; Joel Starkopf; Kersti Zilmer; Mihkel Zilmer
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

10.  The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro.

Authors:  Janet J Maguire; Katie L Jones; Rhoda E Kuc; Murray C H Clarke; Martin R Bennett; Anthony P Davenport
Journal:  Cardiovasc Res       Date:  2013-12-09       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.